Catalyst Wire Dossier Catalyst Wire Dossier

HLA-A2 melanoma vaccine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HLA-A2 melanoma vaccine, covering 2017-02-20 to 2017-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma [Phase 2]

See pricing